Read + Share
Amedeo Smart
Independent Medical Education
Yang Y, Zhang Y, Zhao D, Li X, et al. A Novel PRKAR1A::MET Fusion Dramatic Response to Crizotinib in a Patient with Unresectable Lung Cancer. Clin Lung Cancer 2022 Oct 14. pii: S1525-7304(22)00211.PMID: 36323591
Email
LinkedIn
Facebook
Twitter
Privacy Policy